Marshall Wace, LLP Soma Logic, Inc. Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $3.41 Million - $5.48 Million	-1,937,615 Reduced 93.07%	144,183 $364,000
Q3 2023 Nov 14, 2023	SELL	$1.99 - $2.45 $951,040 - $1.17 Million	-477,910 Reduced 18.67%	2,081,798 $4.98 Million
Q4 2022 Feb 14, 2023	SELL	$2.05 - $3.47 $895,476 - $1.52 Million	-436,818 Reduced 14.58%	2,559,708 $6.42 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $383,845 - $3.33 Million	609,278 Added 25.52%	2,996,526 $8.69 Million
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $1.97 Million - $3.81 Million	-461,304 Reduced 16.19%	2,387,248 $10.8 Million
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $2.77 Million - $4.55 Million	391,944 Added 15.95%	2,848,552 $22.8 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $8.33 Million - $11.3 Million	793,740 Added 47.73%	2,456,608 $28.6 Million
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $16.5 Million - $21.2 Million	1,662,868 New	1,662,868 $20.6 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.